AKTX - Akari Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.949M

Cash

13.25M

Avg Qtr Burn

-5.376M

Short % of Float

0.00%

Insider Ownership

16.12%

Institutional Own.

8.92%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Nomacopan Details BP (Bullous Pemphigoid)	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nomacopan Details Hematopoietic stem cell transplantation thrombotic microangiopathies	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nomacopan Details PNH (Paroxysmal Nocturnal Hemoglobinuria)	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nomacopan Details COVID-19	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nomacopan Details AKC (Atopic Keratoconjunctivitis)	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.